Teruo Yamauchi

Teruo Yamauchi, MD, MSMS

This email address is being protected from spambots. You need JavaScript enabled to view it. | (808) 564-3985

Faculty Leader of Clinical Education, University of Hawaiʻi Cancer Center
Associate Member, Cancer Biology Program, Translational and Clinical Research, University of Hawaiʻi Cancer Center

Academic Appointment(s):
Professor (Researcher), University of Hawaiʻi Cancer Center, University of Hawaiʻi at Mānoa

MD, Kagoshima University Faculty of Medicine
MSMS, Clinical and Translational Research, University of South Florida College of Medicine
Hematology and Medical Oncology Fellowship, Moffitt Cancer Center/University of South Florida


06/2005 - Award for Excellence in Student Teaching, University of Hawaiʻi , Department of Medicine
06/2005 - Dr. Jeffrey Nakamura Medical Education Award, Kuakini Medical Center, Honolulu, HI
2007 - 2009 - NCI K12 grant
2007 - 2009 - NIH K30 grant
08/2009 - Master of Science in Medical Sciences, University of South Florida, College of Medicine, Tampa, FL
2008 - AACR/ASCO Workshop:  Methods in Clinical Cancer Research Scholarship for Clinical Fellow

Research Focus

Novel biomarker and therapy development in breast and GI cancers, QOL improvement in cancer patients

Selected Publications

Nagahashi M, Ling YW, Toshikawa C, Hayashida T, Kitagawa Y, Futamura M, Kuwayama T, Nakamura S, Yamauchi H, Yamauchi T, Kaneko K, Kanbayashi C, Sato N, Tsuchida J, Moro K, Nakajima M, Shimada Y, Ichikawa H, Lyle S, Miyoshi Y, Takabe K, Okuda S, Wakai T. (2023). Copy number alteration is an independent prognostic biomarker in triple-negative breast cancer patients. Breast cancer; 30(4) 584-595; Mar 17.

Yazaki S, Hashimoto J, Ogita S, Nakano E, Suzuki K, Yamauchi T. (2020).Lower response to trastuzumab emtansine in metastatic breast cancer patients with human epidermal growth factor receptor 2 immunohistochemistry score of 2 and fluorescence in situ hybridization positive compared with immunohistochemistry score of 3: a retrospective study. Anti-cancer drugs; 31(9) 973-978; Oct 2020.

Yamauchi T, Espinosa Fernandez JR, Imamura CK, Yamauchi H, Jinno H, Takahashi M, Kitagawa Y, Nakamura S, Lim B, Krishnamurthy S, Reuben JM, Liu D, Tripathy D, Chen H, Takebe N, Saya H, Ueno NT. (2018). Dynamic changes in CD44v-positive cells after preoperative anti-HER2 therapy and its correlation with pathologic complete response in HER2-positive breast cancer. Oncotarget; 9(6) 6872-6882; Jan 23.

Natori A, Ogata T, Sumitani M, Kogure T, Yamauchi T, Yamauchi H. (2015). Potential role of pNF-H, a biomarker of axonal damage in the central nervous system, as a predictive marker of chemotherapy-induced cognitive impairment. Clinical Cancer Research: an official journal of the American Association for Cancer Research; 21(6) 1348-52; Mar 15.

Kim R, Yamauchi T, Husain K, Sebti S, Malafa M. (2015). Triciribine Phosphate Monohydrate, an AKT Inhibitor, Enhances Gemcitabine Activity in Pancreatic Cancer Cells. Anticancer Research; 35(9) 4599-604; Sep 2015..